Sven Kantelhardt

Prof. Dr. Sven Kantelhardt


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2023 in Cells
Verified
Journal Article
Open access
PDF file
AMAndreas Müller
Andreas Müller
PWPatrick Weyerhäuser
Patrick Weyerhäuser
NBNancy Berte
Nancy Berte
FJFitriasari Jonin
Fitriasari Jonin
BLBogdan Lyubarskyy
Bogdan Lyubarskyy
EKElla Kim
Ella Kim
Lysosomotropic agent chloroquine was shown to sensitize non-stem glioblastoma cells to radiation in vitro with p53-dependent apoptosis implicated as one of the underlying mechanisms. The in vivo outcomes of chloroquine or its effects on glioblastoma stem cells have not been previously addressed. This study undertakes a combinatorial approach encompassing in vitro, in vivo and in silico investigations to address the relationship between chloroquine-mediated radiosensitization and p53 status in glioblastoma stem cells. Our findings reveal that chloroquine elicits antagonistic impacts on signaling pathways involved in the regulation of cell fate via both transcription-dependent and transcription-independent mechanisms. Evidence is provided that transcriptional impacts of chloroquine are primarily determined by p53 with chloroquine-mediated activation of pro-survival mevalonate and p21-DREAM pathways being the dominant response in the background of wild type p53. Non-transcriptional effects of chloroquine are conserved and converge on key cell fate regulators ATM, HIPK2 and AKT in glioblastoma stem cells irrespective of their p53 status. Our findings indicate that pro-survival responses elicited by chloroquine predominate in the context of wild type p53 and are diminished in cells with transcriptionally impaired p53. We conclude that p53 is an important determinant of the balance between pro-survival and pro-death impacts of chloroquine and propose that p53 functional status should be taken into consideration when evaluating the efficacy of glioblastoma radiosensitization by chloroquine.

4 January 2015 in International Journal of Computer Assisted Radiology and Surgery
Verified
Journal Article
Closed access
PDF file
SKSven Kantelhardt
Sven Kantelhardt
UHU. Hausen
U. Hausen
MKM. Kosterhon
M. Kosterhon
AAA. N. Amr
A. N. Amr
KGK. Gruber
K. Gruber
AGA. Giese
A. Giese